SNOA – sonoma pharmaceuticals, inc. (US:NASDAQ)

News

Sonoma Pharmaceuticals (NASDAQ:SNOA) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced [Yahoo! Finance]
Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf [Yahoo! Finance]
Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals [Yahoo! Finance]
Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com